Global Prostatic Artery Embolization Market- Drivers
Prostatic artery embolization is more effective than surgical prostate gland enlargement. Prostatic artery embolization has several advantages compared to surgical procedures such as less morbidity, fast recovery. Moreover, the prostatic artery embolization is short invasive treatment than traditional prostatic treatment. Therefore, several healthcare facilities are implementing prostatic artery embolization treatment due to its efficiency and safety. According to the University of California and San Francisco (UCSF), Department of Radiology and Bio-medical Imaging, there is a growing adoption of prostatic artery embolization procedures among physicians in the U.S. due to the procedure’s less invasive nature compared to traditional surgical procedures. These factors are expected to support global prostatic artery embolization market growth during the forecast period.
Global Prostatic Artery Embolization Market- Impact of COVID-19
The COVID-19 pandemic has impacted growth of various markets, and it is also expected to hamper the growth of the global prostatic artery embolization market during the forecast period. Moreover, implementation of nationwide lockdown in several countries and safety precautions suggested by World Health Organization to decrease the risk of spread of COVID-19 while performing surgical procedures it has become very difficult to conduct surgical procedures in patients.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients